The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

Thu, 11th Feb 2021 11:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

MediaZest, more than trebled to 0.16 pence, 12-month range 0.0150p-0.1788p. The audio visual services firm has made a strong start to calendar year 2021, sealing new business wins. In total, new business wins will generate over GBP350,000 in revenue. The stock had closed at 0.050p on Wednesday.

----------

Clear Leisure, up 68% at 1.15 pence, 12-month range 0.110p-1.365p. The company seals GBP680,000 of extra cash through a placing of 113.3 million shares at 0.60 pence each. The technology sector-focused investor will use the funds for working capital and for "selective" further investments.

----------

N4 Pharma, up 14% at 9.24 pence, 12-month range 2.00p-16.00p. The Derbyshire-based pharmaceutical company reports the European Commission intends to grant a patent for Nuvec, a potential cancer treatment. N4 has "exclusive worldwide rights" for Nuvec.

----------

AIM - LOSERS

----------

Europa Oil & Gas, down 18% at 1.35p, 12-month range 0.550p-2.100p. The UK, Ireland and Morocco-focused oil and gas explorer plans to raise GBP2 million through a placing and broker option, priced at 1.3p per share, a 21% discount to its 1.65p closing price on Wednesday. Funds will go towards furthering its UK fields, the Inezgane licence in Morocco and "evaluating late-stage appraisal/development projects".

----------

Eden Research, down 7.8% at 13.77p, 12-month range 4.42p-17.00p. The plastic-free formulation technology company expects revenue for 2020 to come in at GBP1.6 million, a 20% fall, with its pretax loss stretching to GBP2.6 million from GBP1.4 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2019 12:00

N4 Pharma raises £1.05m in placing to advance vaccine delivery system

(Sharecast News) - Specialist pharmaceutical company N4 Pharma said on Friday that it has raised £1.05m before expenses in a placing of 10.5m new ordinary shares to fund its vaccine delivery system.

Read more
20 Dec 2018 15:06

N4 Pharma extends 'Nuvec' licence agreement with Aussie university firm

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has extended the terms of its licence agreement with UniQuest - a University of Queensland company - for the exploitation of its novel delivery system 'Nuvec' on Thursday.

Read more
28 Nov 2018 11:30

N4 Pharma bears more good news on its Nuvec particles

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated on the latest key research findings for its 'Nuvec' delivery system on Wednesday.

Read more
28 Nov 2018 11:20

N4 Pharma Shares Boosted By Positive Nuvec System Results

LONDON (Alliance News) - N4 Pharma PLC shares were up on Wednesday after encouraging research on its Nuvec delivery system.Shares in the pharma company were up 26% at 10.74 pence on Nuvec a

Read more
5 Nov 2018 10:57

WINNERS & LOSERS SUMMARY: Micro Focus Rises On Outlook And Buyback

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus up

Read more
29 Oct 2018 11:32

N4 Pharma pleased with latest test results on 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the latest key research findings for its 'Nuvec' delivery system on Monday, reporting that the Nuvec particles had a "clear adjuvant effect" to help deliver a level of immune response for both the mRNA and pDNA OVA antigens, comparable to that of existing delivery systems.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 09:46

N4 Pharma Shares Rise Following Positive Research Results For Nuvec

LONDON (Alliance News) - Shares rose in N4 Pharma PLC on Monday as a key research study demonstrated positive results for the company's Nuvec delivery system.Shares in the vaccine and a

Read more
2 Oct 2018 12:08

N4 Pharma Commissions Research Programme With Gowans Laboratory

LONDON (Alliance News) - N4 Pharma PLC said Tuesday it commissioned a research program with the Gowans laboratory in the University of Adelaide to investigate its Nuvec system's potential to a

Read more
24 Sep 2018 10:48

WINNERS & LOSERS SUMMARY: Thomas Cook Slumps After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Sky,

Read more
20 Sep 2018 10:30

N4 Pharma To Close Generic Unit After Failed Trials; Loss Narrows

LONDON (Alliance News) - Shares in N4 Pharma PLC dropped on Thursday as the company said it will close its Generic unit after the failure of Sildenafil trials.Shares in the pharmaceutical a

Read more
20 Sep 2018 10:30

WINNERS & LOSERS SUMMARY: Rio Tinto Up On Plan To Return Sale Proceeds

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rio up 1.9%.

Read more
20 Sep 2018 09:49

N4 Pharma calls it a day on generics division, losses widen

(Sharecast News) - After undertaking a strategic review, N4 Pharma directors have decided to discontinue further development of Sildenafil and shutter the rest of its generics division.

Read more
9 Jul 2018 10:08

WINNERS & LOSERS SUMMARY: Centamin Falls After Gold Production Drops

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Just up 2.4%.

Read more
9 Jul 2018 08:40

N4 Pharma Shares Fall As Sildenafil Trial Falls Short Of Expectations

LONDON (Alliance News) - Shares in N4 Pharma PLC plunged early Monday as the company said that its sildenafil reformulation clinical trial has not met its key target endpoints.Shares in the

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.